UK Markets close in 2 hrs 16 mins

Denali Therapeutics Inc. (DNLI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
30.93+0.74 (+2.45%)
At close: 04:00PM EDT
30.93 0.00 (0.00%)
Pre-market: 09:12AM EDT
Currency in USD

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 1.81
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 379.70
52-week low 320.24
50-day moving average 324.91
200-day moving average 337.50

Share statistics

Avg vol (3-month) 3600.58k
Avg vol (10-day) 3993.71k
Shares outstanding 5122.13M
Implied shares outstanding 6N/A
Float 894.95M
% held by insiders 120.54%
% held by institutions 179.38%
Shares short (28 Apr 2022) 46.66M
Short ratio (28 Apr 2022) 415.36
Short % of float (28 Apr 2022) 48.06%
Short % of shares outstanding (28 Apr 2022) 45.42%
Shares short (prior month 30 Mar 2022) 46.74M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-607.78%

Management effectiveness

Return on assets (ttm)-12.29%
Return on equity (ttm)-27.51%

Income statement

Revenue (ttm)48.66M
Revenue per share (ttm)0.40
Quarterly revenue growth (yoy)-96.10%
Gross profit (ttm)-216.69M
EBITDA -287.16M
Net income avi to common (ttm)-290.58M
Diluted EPS (ttm)0.24
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)865.41M
Total cash per share (mrq)7.05
Total debt (mrq)64.01M
Total debt/equity (mrq)6.65
Current ratio (mrq)2.37
Book value per share (mrq)8.30

Cash flow statement

Operating cash flow (ttm)-211.39M
Levered free cash flow (ttm)200.41M